Phase I-II trial designs: How early should efficacy guide the dose recommendation process?

X. Paoletti, S. Postel-Vinay

Résultats de recherche: Contribution à un journal › Editorial

10 Citations (Scopus)

Accès au document

@article{91799d60750b402f9260e8bcd011ac5c,

title = "Phase I-II trial designs: How early should efficacy guide the dose recommendation process?",

author = "X. Paoletti and S. Postel-Vinay",

year = "2018",

month = mar,

day = "1",

doi = "10.1093/annonc/mdy044",

language = "English",

volume = "29",

pages = "540--541",

journal = "Annals of Oncology",

issn = "0923-7534",

number = "3",

}

TY - JOUR

T1 - Phase I-II trial designs

T2 - How early should efficacy guide the dose recommendation process?

AU - Paoletti, X.

AU - Postel-Vinay, S.

PY - 2018/3/1

Y1 - 2018/3/1

UR - http://www.scopus.com/inward/record.url?scp=85046096106&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdy044

DO - 10.1093/annonc/mdy044

M3 - Editorial

C2 - 29415188

AN - SCOPUS:85046096106

SN - 0923-7534

VL - 29

SP - 540

EP - 541

JO - Annals of Oncology

JF - Annals of Oncology

IS - 3

ER -